...
首页> 外文期刊>International journal of molecular medicine >Analysis of the oncogene BRAF mutation and the correlation of the expression of wild-type BRAF and CREB1 in endometriosis
【24h】

Analysis of the oncogene BRAF mutation and the correlation of the expression of wild-type BRAF and CREB1 in endometriosis

机译:癌烯BRAF突变分析及野生型BRAF和CREB1表达在子宫内膜异位症中的相关性

获取原文
获取原文并翻译 | 示例
           

摘要

B-Raf proto-oncogene, serine/threonine kinase (BRAF) has previously been identified as a candidate target gene in endometriosis. Wild-type and mutated BRAF serve important roles in different diseases. The aim of the present study was to explore BRAF mutation, the mRNA and protein expression of wild-type BRAF ((wt)BRAF) in endometriosis, and the association between the expression levels of (wt)BRAF and the predicted transcription factor cAMP responsive element binding protein 1 (CREB1). In the present study, BRAF mutation was detected using Sanger sequencing among 30 ectopic and matched eutopic endometrium samples of patients with endometriosis as well as 25 normal endometrium samples, and no BRAF mutation was detected in exons 11 or 15. A region of similar to 2,000 bp upstream of the BRAF gene was then screened using NCBI and UCSC databases, and CREB1 was identified as a potential transcription factor of BRAF by analysis with the JASPAR and the TRANSFAC databases. Quantitative polymerase chain reaction was used to analysis the mRNA expression levels of wtBRAF and CREB1, and the corresponding protein expression levels were evaluated using immunohistochemistry and western blot analysis. The results revealed that the mRNA and protein expression levels of (wt)BRAF and CREB1 were significantly upregulated in the eutopic endometrial tissues of patients with endometriosis compared with normal endometrial tissues (P0.05) and no significant difference in (wt)BRAF and CREB1 levels was detected between the ectopic and eutopic endometrium (P0.05). In addition, correlation analysis revealed that the protein expression of CREB1 was positively correlated with the transcript level and protein expression of (wt)BRAF. It is reasonable to speculate that CREB1 may activate the transcription of (wt)BRAF through directly binding to its promoter, increasing BRAF expression and regulating the cell proliferation, migration and invasion of endometriosis.
机译:B-RAF原癌基因,丝氨酸/苏氨酸激酶(BRAF)先前已被鉴定为子宫内膜异位症的候选靶基因。野生型和突变的BRAF在不同疾病中提供重要作用。本研究的目的是探索野生型BRAF((重量)BRAF)的BRAF突变,野生型BRAF((重量)BRAF)的蛋白表达,以及(WT)BRAF的表达水平与预测转录因子阵营的关联响应于元素结合蛋白1(CREB1)。在本研究中,使用子宫内膜异位症患者的30个异位和匹配的陪孔子宫内膜样品以及25个正常子宫内膜样品中的伴有Sanger测序检测到BRAF突变,并且在外显子11或15中没有检测到BRAF突变。一个类似于2,000的区域然后使用NCBI和UCSC数据库筛选BRAF基因上游的BP,并且通过用JASPAR和Transfac数据库分析,通过分析鉴定CREB1作为BRAF的潜在转录因子。定量聚合酶链反应用于分析WTBRAF和CREB1的mRNA表达水平,并使用免疫组化和Western印迹分析评估相应的蛋白质表达水平。结果表明,与正常子宫内膜组织(P <0.05)相比,子宫内膜异位症患者的陪孔子宫内膜组织中,(重量)BRAF和CREB1的mRNA和蛋白表达水平明显上调(WT)BRAF和CREB1没有显着差异在异位和渗透子宫内膜之间检测水平(P&GT; 0.05)。此外,相关性分析显示CREB1的蛋白表达与(WT)BRAF的转录水平和蛋白质表达呈正相关。推测CREB1可以通过直接结合其启动子,增加BRAF表达和调节子宫内膜异位症的细胞增殖,迁移和侵袭,所述CREB1可以激活(WT)BRAF的转录。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号